Last updated: 14 March 2019 at 1:10am EST

Pedro Alvaro Amorrortu Net Worth




The estimated Net Worth of Pedro Alvaro Amorrortu is at least $2.01 Million dollars as of 4 January 2019. Pedro Amorrortu owns over 9,000 units of Solid Biosciences Inc stock worth over $1,183,765 and over the last 7 years Pedro sold SLDB stock worth over $827,640.

Pedro Amorrortu SLDB stock SEC Form 4 insiders trading

Pedro has made over 3 trades of the Solid Biosciences Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Pedro sold 9,000 units of SLDB stock worth $270,630 on 4 January 2019.

The largest trade Pedro's ever made was selling 9,000 units of Solid Biosciences Inc stock on 4 January 2019 worth over $270,630. On average, Pedro trades about 5,400 units every 10 days since 2018. As of 4 January 2019 Pedro still owns at least 158,046 units of Solid Biosciences Inc stock.

You can see the complete history of Pedro Amorrortu stock trades at the bottom of the page.



What's Pedro Amorrortu's mailing address?

Pedro's mailing address filed with the SEC is C/O SOLID BIOSCIENCES INC., 141 PORTLAND STREET, 5TH FLOOR, CAMBRIDGE, MA, 02139.

Insiders trading at Solid Biosciences Inc

Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ..., and Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.



What does Solid Biosciences Inc do?

solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.



Complete history of Pedro Amorrortu stock trades at Solid Biosciences Inc

Insider
Trans.
Transaction
Total value
Pedro Alvaro Amorrortu
Chief Operating Officer
Sale $270,630
4 Jan 2019
Pedro Alvaro Amorrortu
Chief Operating Officer
Sale $279,540
3 Dec 2018
Pedro Alvaro Amorrortu
Chief Operating Officer
Sale $277,470
15 Nov 2018


Solid Biosciences Inc executives and stock owners

Solid Biosciences Inc executives and other stock owners filed with the SEC include: